140 related articles for article (PubMed ID: 34766717)
1. Regression and pseudoprogression of pediatric optic pathway glioma in patients treated with proton beam therapy.
Youn SH; Kim H; Lee SH; Kim JY
Pediatr Blood Cancer; 2022 Mar; 69(3):e29434. PubMed ID: 34766717
[TBL] [Abstract][Full Text] [Related]
2. Pseudoprogression Is Frequent After Front-Line Radiation Therapy in Pediatric Low-Grade Glioma: Results From the German Low-Grade Glioma Cohort.
Stock A; Hancken CV; Kandels D; Kortmann RD; Dietzsch S; Timmermann B; Pietsch T; Bison B; Schmidt R; Pham M; Gnekow AK; Warmuth-Metz M
Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1190-1202. PubMed ID: 34933039
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapy.
Ludmir EB; Mahajan A; Paulino AC; Jones JY; Ketonen LM; Su JM; Grosshans DR; McAleer MF; McGovern SL; Lassen-Ramshad YA; Adesina AM; Dauser RC; Weinberg JS; Chintagumpala MM
Neuro Oncol; 2019 May; 21(5):686-695. PubMed ID: 30753704
[TBL] [Abstract][Full Text] [Related]
4. Neurosurgical management of proton beam therapy-induced moyamoya syndrome.
Zhang CH; Muirhead W; Silva AHD; Toolis C; Robertson F; Rennie A; Bhate S; Thompson DNP; Ganesan V; James G
J Neurosurg Pediatr; 2023 Apr; 31(4):369-379. PubMed ID: 36738468
[TBL] [Abstract][Full Text] [Related]
5. Radiation-Induced Cerebral Microbleeds in Pediatric Patients With Brain Tumors Treated With Proton Radiation Therapy.
Kralik SF; Mereniuk TR; Grignon L; Shih CS; Ho CY; Finke W; Coleman PW; Watson GA; Buchsbaum JC
Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1465-1471. PubMed ID: 30092336
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes of Proton Beam Therapy for Choroidal Melanoma at a Single Institute in Korea.
Kim TW; Choi E; Park J; Shin DH; Jung SK; Seok S; Cho KH; Kim JY; Kim DY; Kim TH; Suh YK; Kim YJ; Moon SH
Cancer Res Treat; 2018 Apr; 50(2):335-344. PubMed ID: 28421723
[TBL] [Abstract][Full Text] [Related]
7. Early radiotherapy preserves vision in sporadic optic pathway glioma.
Hanania AN; Paulino AC; Ludmir EB; Shah VS; Su JM; McGovern SL; Baxter PA; McAleer MF; Grosshans DR; Okcu MF; Chintagumpala MM
Cancer; 2021 Jul; 127(13):2358-2367. PubMed ID: 33739455
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of neuroimaging findings post-proton beam therapy in a large pediatric cohort.
Bhattacharya D; Chhabda S; Lakshmanan R; Tan R; Warne R; Benenati M; Michalski A; Aquilina K; Jacques T; Hargrave D; Chang YC; Gains J; Mankad K
Childs Nerv Syst; 2021 Feb; 37(2):435-446. PubMed ID: 32705327
[TBL] [Abstract][Full Text] [Related]
9. [Results of fractionated targeted proton beam therapy in the treatment of primary optic nerve sheath meningioma].
Moyal L; Vignal-Clermont C; Boissonnet H; Alapetite C
J Fr Ophtalmol; 2014 Apr; 37(4):288-95. PubMed ID: 24629446
[TBL] [Abstract][Full Text] [Related]
10. Extended Volumetric Follow-up of Juvenile Pilocytic Astrocytomas Treated with Proton Beam Therapy.
Mannina EM; Bartlett GK; McMullen KP
Int J Part Ther; 2016; 3(2):291-299. PubMed ID: 31772980
[TBL] [Abstract][Full Text] [Related]
11. Treatment evaluation by volumetric segmentation in pediatric optic pathway glioma: evaluation of the effect of bevacizumab on intra-tumor components.
Bennebroek CA; Schouten CR; Montauban-van Swijndregt MC; Saeed P; Porro GL; Pott JWR; Dittrich ATM; Oostenbrink R; Schouten-van Meeteren AY; de Jong MC; de Graaf P
J Neurooncol; 2024 Jan; 166(1):79-87. PubMed ID: 38150061
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Focal Liver Reaction after Proton Beam Therapy for Hepatocellular Carcinoma Examined Using Gd-EOB-DTPA Enhanced Hepatic Magnetic Resonance Imaging.
Takamatsu S; Yamamoto K; Maeda Y; Kawamura M; Shibata S; Sato Y; Terashima K; Shimizu Y; Tameshige Y; Sasaki M; Asahi S; Kondou T; Kobayashi S; Matsui O; Gabata T
PLoS One; 2016; 11(12):e0167155. PubMed ID: 27907063
[TBL] [Abstract][Full Text] [Related]
13. A Retrospective Study of Renal Growth Changes after Proton Beam Therapy for Pediatric Malignant Tumor.
Li Y; Mizumoto M; Oshiro Y; Nitta H; Saito T; Iizumi T; Kawano C; Yamaki Y; Fukushima H; Hosaka S; Maruo K; Kamizawa S; Sakurai H
Curr Oncol; 2023 Jan; 30(2):1560-1570. PubMed ID: 36826081
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of Proton Beam Therapy for Infants with Brain Tumours: Experiences from the Prospective KiProReg Registry Study.
Jazmati D; Steinmeier T; Ahamd Khalil D; Frisch S; Peters S; Schulze Schleithoff S; Bäumer C; Rutkowski S; Frühwald MC; Blase C; Tippelt S; Timmermann B
Clin Oncol (R Coll Radiol); 2021 Jul; 33(7):e295-e304. PubMed ID: 33820696
[TBL] [Abstract][Full Text] [Related]
15. Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1.
Wan MJ; Ullrich NJ; Manley PE; Kieran MW; Goumnerova LC; Heidary G
J Neurooncol; 2016 Aug; 129(1):173-8. PubMed ID: 27311725
[TBL] [Abstract][Full Text] [Related]
16. The role of surgery in optic pathway/hypothalamic gliomas in children.
Goodden J; Pizer B; Pettorini B; Williams D; Blair J; Didi M; Thorp N; Mallucci C
J Neurosurg Pediatr; 2014 Jan; 13(1):1-12. PubMed ID: 24138145
[TBL] [Abstract][Full Text] [Related]
17. Proton beam therapy for pediatric malignancies: a retrospective observational multicenter study in Japan.
Mizumoto M; Murayama S; Akimoto T; Demizu Y; Fukushima T; Ishida Y; Oshiro Y; Numajiri H; Fuji H; Okumura T; Shirato H; Sakurai H
Cancer Med; 2016 Jul; 5(7):1519-25. PubMed ID: 27165972
[TBL] [Abstract][Full Text] [Related]
18. Visual acuity of children treated with chemotherapy for optic pathway gliomas.
Kalin-Hajdu E; Décarie JC; Marzouki M; Carret AS; Ospina LH
Pediatr Blood Cancer; 2014 Feb; 61(2):223-7. PubMed ID: 23956233
[TBL] [Abstract][Full Text] [Related]
19. Visual outcomes of proton beam therapy for choroidal melanoma at a single institute in the Republic of Korea.
Jung SK; Park YH; Shin DH; Kim HS; Jung JH; Kim TH; Moon SH
PLoS One; 2020; 15(12):e0242966. PubMed ID: 33264363
[TBL] [Abstract][Full Text] [Related]
20. Proton therapy of iris melanoma with 50 CGE : Influence of target volume on clinical outcome.
Riechardt AI; Karle B; Cordini D; Heufelder J; Budach V; Joussen AM; Gollrad J
Strahlenther Onkol; 2017 Nov; 193(11):943-950. PubMed ID: 28631017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
